scholarly journals Visualization of Protease Activity In Vivo Using an Activatable Photo-Acoustic Imaging Probe Based on CuS Nanoparticles

Theranostics ◽  
2014 ◽  
Vol 4 (2) ◽  
pp. 134-141 ◽  
Author(s):  
Kai Yang ◽  
Lei Zhu ◽  
Liming Nie ◽  
Xiaolian Sun ◽  
Liang Cheng ◽  
...  
2008 ◽  
Vol 120 (15) ◽  
pp. 2846-2849 ◽  
Author(s):  
Seulki Lee ◽  
Eui-Joon Cha ◽  
Kyeongsoon Park ◽  
Seung-Young Lee ◽  
Jin-Ki Hong ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (15) ◽  
pp. 4699
Author(s):  
Mubashir Mintoo ◽  
Amritangshu Chakravarty ◽  
Ronak Tilvawala

Proteases play a central role in various biochemical pathways catalyzing and regulating key biological events. Proteases catalyze an irreversible post-translational modification called proteolysis by hydrolyzing peptide bonds in proteins. Given the destructive potential of proteolysis, protease activity is tightly regulated. Dysregulation of protease activity has been reported in numerous disease conditions, including cancers, neurodegenerative diseases, inflammatory conditions, cardiovascular diseases, and viral infections. The proteolytic profile of a cell, tissue, or organ is governed by protease activation, activity, and substrate specificity. Thus, identifying protease substrates and proteolytic events under physiological conditions can provide crucial information about how the change in protease regulation can alter the cellular proteolytic landscape. In recent years, mass spectrometry-based techniques called N-terminomics have become instrumental in identifying protease substrates from complex biological mixtures. N-terminomics employs the labeling and enrichment of native and neo-N-termini peptides, generated upon proteolysis followed by mass spectrometry analysis allowing protease substrate profiling directly from biological samples. In this review, we provide a brief overview of N-terminomics techniques, focusing on their strengths, weaknesses, limitations, and providing specific examples where they were successfully employed to identify protease substrates in vivo and under physiological conditions. In addition, we explore the current trends in the protease field and the potential for future developments.


ACS Omega ◽  
2021 ◽  
Vol 6 (5) ◽  
pp. 3809-3821
Author(s):  
Roman A. Barmin ◽  
Polina G. Rudakovskaya ◽  
Vasiliy S. Chernyshev ◽  
Olga I. Guslyakova ◽  
Pavel A. Belcov ◽  
...  

2009 ◽  
Vol 29 (10) ◽  
pp. 1444-1451 ◽  
Author(s):  
Matthias Nahrendorf ◽  
Peter Waterman ◽  
Greg Thurber ◽  
Kevin Groves ◽  
Milind Rajopadhye ◽  
...  
Keyword(s):  

1988 ◽  
Vol 91 (2) ◽  
pp. 281-286
Author(s):  
M.C. Copeman ◽  
H. Harris

It has been shown that when malignant tumour cells are fused with normal fibroblasts the suppression of malignancy in the hybrids is linked to their ability to produce a collagenous extracellular matrix in vivo. When, as a consequence of chromosome loss, segregants arise that reacquire malignancy, these do not produce any detectable matrix. In this paper we examine the main components of the extracellular matrix produced in vitro by hybrids between malignant mouse melanoma cells and normal mouse fibroblasts. Hybrids in which malignancy is suppressed synthesize about ten times as much type 1 procollagen as the malignant segregants derived from them; they also retain more fibronectin in the cell layer and release less protease activity into the medium. Malignant segregants more closely resemble the parental melanoma cells in producing fibronectin and mainly types IV and V procollagen. When hybrid cells in which malignancy is initially suppressed are grown continuously in vitro, the production of type I procollagen declines, and the production of type V procollagen and the release of protease activity into the medium increase. These changes, which are associated with the loss from the hybrid cells of both copies of the chromosome 4 derived from the parental fibroblast, predict the reacquisition of malignancy when the cells are inoculated into mice. It is possible that one gene or set of genes located on chromosome 4 determines both the execution of the fibroblast differentiation programme and the suppression of malignancy.


2014 ◽  
Vol 22 (10) ◽  
pp. 1461-1469 ◽  
Author(s):  
P.B. Satkunananthan ◽  
M.J. Anderson ◽  
N.M. De Jesus ◽  
D.R. Haudenschild ◽  
C.M. Ripplinger ◽  
...  

2010 ◽  
Vol 6 (5) ◽  
pp. 888 ◽  
Author(s):  
Mikako Ogawa ◽  
Nobuyuki Kosaka ◽  
Celeste A. S. Regino ◽  
Makoto Mitsunaga ◽  
Peter L. Choyke ◽  
...  

2015 ◽  
Vol 112 (5) ◽  
pp. 1577-1582 ◽  
Author(s):  
Lars Ketscher ◽  
Ronny Hannß ◽  
David J. Morales ◽  
Anja Basters ◽  
Susana Guerra ◽  
...  

Protein modification by the ubiquitin-like protein ISG15 is an interferon (IFN) effector system, which plays a major role in antiviral defense. ISG15 modification is counteracted by the isopeptidase USP18, a major negative regulator of IFN signaling, which was also shown to exert its regulatory function in an isopeptidase-independent manner. To dissect enzymatic and nonenzymatic functions of USP18 in vivo, we generated knock-in mice (USP18C61A/C61A) expressing enzymatically inactive USP18. USP18C61A/C61A mice displayed increased levels of ISG15 conjugates, validating that USP18 is a major ISG15 isopeptidase in vivo. Unlike USP18−/− mice, USP18C61A/C61A animals did not exhibit morphological abnormalities, fatal IFN hypersensitivity, or increased lethality, clearly showing that major USP18 functions are unrelated to its protease activity. Strikingly, elevated ISGylation in USP18C61A/C61A mice was accompanied by increased viral resistance against vaccinia virus and influenza B virus infections. Enhanced resistance upon influenza B infection in USP18C61A/C61A mice was completely reversed in USP18C61A/C61A mice, which additionally lack ISG15, providing evidence that the observed reduction in viral titers is ISG15 dependent. These results suggest that increasing ISGylation by specific inhibition of USP18 protease activity could constitute a promising antiviral strategy with only a minimal risk of severe adverse effects.


Author(s):  
N. Kiran Kumar ◽  
P. Nagamani ◽  
K. Viswanath ◽  
L. Prasanthi

Background: The plant growth promotion and efficacy against phytopathogens by the endophytic bacteria are being focused now due to their ecofriendly nature. Methods: Endophytic bacteria (24 nos) isolated from the roots, stems and leaves of black gram plants collected from different locations were tested for their potential to inhibit the growth of R. bataticola under in vitro and in vivo conditions. Result: The leaf endophyte BLE 4 exhibited maximum inhibition (79.6%) of R. bataticola followed by BSE 4 (77.4%), BSE 7 (77.0%) and BLE 1 (74.0%). Among these 4 isolates tested as seed treatment and soil application, there was significant increase in dry weight (7.1 g), plant height (37.7 cm), number of branches (13.2) and number of pods (26.2) in BLE 4 treated plots. Whereas, the incidence of dry root rot and yield were insignificant. In the screening study of isolates for their phosphate solubilization potential, protease activity, siderophore and HCN production, no single isolate possessed all the properties, but siderophore production, protease activity and phosphate solubilization were found in BSE 4, BRE 3, BRE 5 and BRE 10 isolates. 


Sign in / Sign up

Export Citation Format

Share Document